Importer of Controlled Substances Application: Adiramedica LLC, 81220-81221 [2020-27509]
Download as PDF
<![CDATA[
81220
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
and online at https://eplanning.blm.gov/
eplanning-ui/project/2000251/510.
This Notice informs the public of an
application submitted by the Fry Fire
District, Arizona, for a non-competitive
sale and conveyance of the reversionary
interests of public land in Cochise
County for the District’s Recreation and
Public Purposes Act patent 02–85–0038,
held since 1985, for a fire station.
The conveyance is requested by the
Fry Fire District in order to
commercially lease its facilities, which
is currently prohibited under the
Recreation and Public Purposes patent it
holds. This would enable the Fry Fire
District to commercially lease its
facilities, including placement of
infrastructure such as cell towers,
generating revenue to support its
firefighting and emergency medical
services to the public.
Issuance of the document of
conveyance, a new patent, is in
accordance with the 1992 Safford
District Resource Management Plan
(DOI–BLM–AZ–G010–1992–RMP–EIS)
and the 1994 Land Tenure Amendment
to the Safford District Resource
Management Plan (EA/Decision Record
No. AZ–040–04–12). Conveyance of the
reversionary interest in the land is
consistent with applicable Federal and
county land use plans and meets the
needs of the community. The land is not
required for any other Federal purpose.
This disposal would not impede access
to Federal lands used for recreation, as
the Federal lands in the vicinity would
continue to have public access.
Application Comments: Interested
parties may submit comments regarding
the specific use proposed in the
application or any other factor not
directly related to the sale of the
reversionary interest. The BLM will
review and determine the validity of
any adverse comments. In the absence
of any adverse comments, the decision
will become final. The lands will not be
offered for conveyance until a
determination of significance and
Decision Record have been signed for
the completed Environmental
Assessment DOI–BLM–AZ–A020–2020–
0029–EA found at: https://
eplanning.blm.gov/eplanning-ui/
project/2000251/510.
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment, including your
personal identifying information, may
be made available to the public at any
time. While you can ask in your
comment to withhold your personal
identifying information from public
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
review, we cannot guarantee that we
will be able to do so.
Authority: 43 CFR 2711.
Jayme M. Lopez,
Field Manager.
[FR Doc. 2020–27556 Filed 12–14–20; 8:45 am]
BILLING CODE 4310–32–P
reference to dug codes 7350 (Marihuana
Extract), 7360 (Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–27512 Filed 12–14–20; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE P
Drug Enforcement Administration
[Docket No. DEA–755]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Sterling
Wisconsin, LLC
Drug Enforcement Administration
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Importer of Controlled Substances
Application: Adiramedica LLC
Sterling Wisconsin, LLC has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before February 16, 2021. Such
persons may also file a written request
for a hearing on the application on or
before February 16, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on October 15, 2020,
Sterling Wisconsin, LLC, W130N10497
Washington Drive, Germantown,
Wisconsin 53022–4448, applied to be
registered as an bulk manufacturer of
the following basic class(es) of
controlled substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
Controlled substance
Marihuana Extract ....................
Marihuana ................................
Tetrahydrocannabinols ............
5-Methoxy-N–NDimethyltryptamine.
Oliceridine ................................
Thebaine ..................................
Alfentanil ..................................
Schedule
7350
7360
7370
7431
I
I
I
I
9245
9333
9737
II
II
II
The company plans to bulk
manufacture the listed controlled
substances to be commercially sold to
registered manufacturers/suppliers. In
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
[Docket No. DEA–753]
Drug Enforcement
Administration, Justice.
AGENCY:
ACTION:
Notice of application.
Adiramedica LLC has applied
to be registered as an importer of a basic
class of a controlled substance. Refer to
Supplemental Information listed below
for further drug information.
SUMMARY:
Registered bulk manufacturers of
the affected basic class, and applicants
therefore, may file written comments on
or objections to the issuance of the
proposed registration on or before
January 14, 2021. Such persons may
also file a written request for a hearing
on the application on or before January
14, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on October 14, 2020,
Adiramedica LLC, 585 Turner Industrial
Way, Aston, Pennsylvania 19014,
applied to be registered as an importer
of the following basic class of a
controlled substance:
SUPPLEMENTARY INFORMATION:
E:\FR\FM\15DEN1.SGM
15DEN1
Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices
Controlled substance
Tapentadol ....................
Drug
code
Schedule
9780
II
The company plans to import
Tapentadol in dosage form for clinical
trials. No other activity for this drug
code is authorized for this registration.
Approval of permit applications will
occur only when the registrant’s activity
is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization
will not extend to the import of Food
and Drug Administration-approved or
non-approved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–27509 Filed 12–14–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF LABOR
Employment and Training
Administration
Labor Certification Process for the
Temporary Employment of Aliens in
Agriculture in the United States:
Adverse Effect Wage Rate for Range
Occupations in 2021
Employment and Training
Administration (ETA), Labor.
ACTION: Notice.
AGENCY:
Adverse Effect Wage Rate for 2021
The Employment and
Training Administration (ETA) of the
Department of Labor (Department) is
issuing this notice to announce the 2021
Adverse Effect Wage Rate (AEWR) for
the employment of temporary or
seasonal nonimmigrant foreign workers
(H–2A workers) to perform herding or
production of livestock on the range.
AEWRs are the minimum wage rates the
Department has determined must be
offered and paid by employers to H–2A
workers and workers in corresponding
employment so that the wages and
working conditions of workers in the
United States (U.S.) similarly employed
will not be adversely affected. In this
notice, the Department announces the
annual update of the AEWR for workers
engaged in the herding or production of
livestock on the range, as required by
the methodology established in the
Temporary Agricultural Employment of
H–2A Foreign Workers in the Herding or
Production of Livestock on the Range in
the United States, 80 FR 62958, 63067–
63068 (Oct. 16, 2015); 20 CFR 655.211.
DATES: The rate is effective January 1,
2021.
FOR FURTHER INFORMATION CONTACT:
Brian Pasternak, Administrator, Office
SUMMARY:
VerDate Sep<11>2014
17:35 Dec 14, 2020
Jkt 253001
of Foreign Labor Certification,
Employment and Training
Administration, Department of Labor,
N–5311, 200 Constitution Ave. NW,
Washington, DC 20210, Telephone:
(202) 513–7350 (this is not a toll-free
number). Individuals with hearing or
speech impairments may access the
telephone number above via TTY by
calling the toll-free Federal Information
Relay Service at 1–877–889–5627 (TTY/
TDD).
SUPPLEMENTARY INFORMATION: The U.S.
Citizenship and Immigration Services of
the Department of Homeland Security
will not approve an employer’s petition
for the admission of H–2A
nonimmigrant temporary and seasonal
agricultural workers in the U.S. unless
the petitioner has received an H–2A
labor certification from the Department.
The H–2A labor certification provides
that (1) there are not sufficient U.S.
workers who are able, willing, and
qualified and who will be available at
the time and place needed to perform
the labor or services involved in the
petition; and (2) the employment of the
foreign worker(s) in such labor or
services will not adversely affect the
wages and working conditions of
workers in the U.S. similarly employed.
8 U.S.C. 1101(a)(15)(H)(ii)(a), 1184(c)(1),
and 1188(a); 8 CFR 214.2(h)(5); 20 CFR
655.100.
The Department’s H–2A regulations
covering the herding or production of
livestock on the range (H–2A Herder
Rule) at 20 CFR 655.210(g) and
655.211(a)(1) provide that employers
must offer, advertise in recruitment, and
pay each worker employed under 20
CFR 655.200–655.235 a wage that is at
least the highest of (1) the monthly
AEWR, (2) the agreed-upon collective
bargaining wage, or (3) the applicable
minimum wage imposed by federal or
state law or judicial action. Further,
when the monthly AEWR is adjusted
during a work contract and is higher
than both the agreed-upon collective
bargaining wage and the applicable
minimum wage imposed by federal or
state law or judicial action in effect at
the time the work is performed, the
employer must pay that adjusted
monthly AEWR upon publication by the
Department in the Federal Register. 20
CFR 655.211(a)(2).
As provided in 20 CFR 655.211(c)(2)
of the H–2A Herder Rule, the monthly
AEWR for range occupations in all
states for a calendar year is based on the
monthly AEWR for the previous
calendar year, adjusted by the
Employment Cost Index (ECI) for wages
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
81221
and salaries published by the Bureau of
Labor Statistics for the preceding annual
period. The 12-month change in the ECI
for wages and salaries of private
industry workers between September
2019 and September 2020 was 2.7
percent, resulting in a monthly AEWR
for range occupations in effect for 2021
of $1,727.75.1 The national monthly
AEWR rate for all range occupations in
the H–2A program in 2021 is calculated
by multiplying the monthly AEWR for
calendar year 2020 by the October 2020
ECI adjustment ($1,682.33 × 1.027 =
$1,727.75) or $1,727.75. Accordingly,
any employer certified or seeking
certification for range workers must pay
each worker a wage that is at least the
highest of the monthly AEWR of
$1,727.75, the agreed-upon collective
bargaining wage, or the applicable
minimum wage imposed by federal or
state legislation or judicial action at the
time work is performed on or after the
effective date of this notice.
John Pallasch,
Assistant Secretary for the Employment and
Training Administration.
[FR Doc. 2020–27468 Filed 12–14–20; 8:45 am]
BILLING CODE 4510–FP–P
DEPARTMENT OF LABOR
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request; Job Corps
Hall of Fame and Successful Graduate
Nomination
Office of the Secretary,
Department of Labor.
AGENCY:
Notice of availability; request
for comments.
ACTION:
The Department of Labor
(DOL) is submitting this Employment
and Training Administration (ETA)sponsored information collection
request (ICR) to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995
SUMMARY:
1 The regulation at 20 CFR 655.211(c)(2) states
that the monthly AEWR is calculated based on the
ECI for wages and salaries ‘‘for the preceding
October—October period.’’ This regulatory language
was intended to identify the Bureau of Labor
Statistics’ October publication of ECI for wages and
salaries, which presents data for the September—
September period. Accordingly, the most recent 12month change in the ECI for private sector workers
published on October 30, 2020, by the Bureau of
Labor Statistics was used for establishing the
monthly AEWR under the regulations. See https://
www.bls.gov/news.release/archives/eci_
10302020.pdf. The ECI for private sector workers
was used rather than the ECI for all civilian workers
given the characteristics of the H–2A herder
workforce.
E:\FR\FM\15DEN1.SGM
15DEN1
]]>Agencies
[Federal Register Volume 85, Number 241 (Tuesday, December 15, 2020)]
[Notices]
[Pages 81220-81221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27509]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-753]
Importer of Controlled Substances Application: Adiramedica LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Adiramedica LLC has applied to be registered as an importer of
a basic class of a controlled substance. Refer to Supplemental
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 14, 2021.
Such persons may also file a written request for a hearing on the
application on or before January 14, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on October 14, 2020, Adiramedica LLC, 585 Turner
Industrial Way, Aston, Pennsylvania 19014, applied to be registered as
an importer of the following basic class of a controlled substance:
[[Page 81221]]
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to import Tapentadol in dosage form for clinical
trials. No other activity for this drug code is authorized for this
registration.
Approval of permit applications will occur only when the
registrant's activity is consistent with what is authorized under 21
U.S.C. 952(a)(2). Authorization will not extend to the import of Food
and Drug Administration-approved or non-approved finished dosage forms
for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-27509 Filed 12-14-20; 8:45 am]
BILLING CODE P
